YIH
TMCI icon

Y-Intercept (HK)’s Treace Medical Concepts TMCI Stock Holding History

Y-Intercept (HK)’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-232,413
Closed -$1.37M – 2050
2025
Q2 		$1.37M Buy
232,413
+201,252
+646% +$1.31M 0.03% 785
2025
Q1 		$261K Buy
+31,161
New +$280K 0.02% 951
2024
Q3 		– Sell
-96,317
Closed -$641K – 1803
2024
Q2 		$641K Buy
96,317
+45,091
+88% +$364K 0.04% 712
2024
Q1 		$668K Buy
+51,226
New +$683K 0.05% 562
2023
Q4 		– Sell
-25,464
Closed -$334K – 1643
2023
Q3 		$334K Buy
+25,464
New +$466K 0.03% 720

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Y-Intercept (HK)'s TMCI Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Treace Medical Concepts (TMCI) in Q3 2025, closing a stake of 232,413 shares — an estimated $1.37M sold.

Y-Intercept (HK) first reported a position in TMCI in Q3 2023 and held it in 5 quarters. The position peaked at $1.37M in Q2 2025. 119 funds tracked by Wall St. Rank hold TMCI as of Q3 2025.

  • Y-Intercept (HK) reported no remaining Treace Medical Concepts position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 232,413 Treace Medical Concepts shares in Q3 2025, an estimated $1.37M.
  • Y-Intercept (HK) first reported a position in Treace Medical Concepts in Q3 2023 and held it in 5 quarters.
  • Y-Intercept (HK)'s Treace Medical Concepts position peaked at $1.37M in Q2 2025.
  • 119 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.